Chinese Covid-19 vaccine starts final tests in Brazil | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Wednesday
November 29, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
WEDNESDAY, NOVEMBER 29, 2023
Chinese Covid-19 vaccine starts final tests in Brazil

Coronavirus chronicle

BSS/AFP
22 July, 2020, 09:20 am
Last modified: 22 July, 2020, 12:25 pm

Related News

  • India to add $5 billion aircraft carrier to fleet to counter China
  • Why is billionaire Jack Ma focusing on food business in China through a new startup ?
  • West's de-risking starts to bite China's prospects
  • Jack Ma gets back into business with ‘Ma’s Kitchen Food’
  • Indian drug manufacturers benefit from Big Pharma interest beyond China

Chinese Covid-19 vaccine starts final tests in Brazil

The vaccine, developed by private Chinese pharmaceutical firm Sinovac Biotech, became the third in the world to enter Phase 3 clinical trials, or large-scale testing on humans — the last step before regulatory approval

BSS/AFP
22 July, 2020, 09:20 am
Last modified: 22 July, 2020, 12:25 pm
Photo :Collected
Photo :Collected

A Chinese-made vaccine against the new coronavirus entered the final stage of testing Tuesday in Brazil, where volunteers received the first doses of what officials hope will be a game-changer in the global pandemic.

The vaccine, developed by private Chinese pharmaceutical firm Sinovac Biotech, became the third in the world to enter Phase 3 clinical trials, or large-scale testing on humans — the last step before regulatory approval.

"We're living in unique and historic times, and that's why I wanted to be part of this trial," said the 27-year-old doctor who received the first dose at the Clinical Hospital of Sao Paulo.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Her name was withheld for confidentiality.

Around 9,000 health workers across six Brazilian states will receive the vaccine, known as CoronaVac, in two doses over the next three months under the study.

Sao Paulo Governor Joao Doria said Monday initial results were expected within 90 days.

Sinovac is partnering with a Brazilian public health research center, the Butantan Institute, on the trials.

If the vaccine proves safe and effective, the institute will have the right to produce 120 million doses under the deal, according to officials.

Brazil is the second-hardest-hit country in the coronavirus pandemic, after the United States.

Its death toll surpassed 80,000 Monday, and it has registered 2.1 million infections.

Because the virus is still spreading quickly in the South American country, it is seen as an ideal testing ground for vaccine candidates.

Brazil is also helping carry out Phase 3 testing of another experimental vaccine, developed by Oxford University and pharmaceutical firm AstraZeneca.

It has a similar deal to produce that vaccine domestically if it is successful in tests, which are also being carried out in Britain and South Africa.

Brazilian health regulators announced Monday they have also authorized Phase 1, 2 and 3 trials of two more vaccines, developed by US firm Pfizer and Germany's BioNTech.

Researchers worldwide are racing to develop and test a vaccine for the virus. There are more than 150 projects so far.

Studies published Monday in British medical journal The Lancet found two vaccine candidates were safe and produced an immune response in Phase 2 trials: the Oxford vaccine and another Chinese-made vaccine, developed by pharmaceutical firm CanSino Biologics and the Beijing Institute of Biotechnology.

Top News / World+Biz

China / Coronavirus Vaccine / Brazil / Trial / Sinovac Biotech

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Taka appreciated officially, market reacts quite opposite
    Taka appreciated officially, market reacts quite opposite
  • Only approved appraisers to assess loan collateral: Cenbank 
    Only approved appraisers to assess loan collateral: Cenbank 
  • A truck burnt in Narayanganj on 28 November 2023. Photo: Collected
    Moving truck set on fire in Sonargaon, helper burnt

MOST VIEWED

  • Tax return time extension likely
    Tax return time extension likely
  •  File photo of a North Korean flag. REUTERS
    North Korea shuts down its embassy in Bangladesh
  • 12 expressways outlined for wider connectivity by 2041
    12 expressways outlined for wider connectivity by 2041
  • Photo: TBS
    Ctg city enters ‘Smart School Bus’ era
  • The architectural design of Anukrom is a triumph of purpose and ingenuity – a rectangular structure that stretches east to west, crafting out two courtyards. Photo: Shakil Hai
    Anukrom: A mother’s dream, a son’s guilt and an award-winning home
  • Bajaj Pulsar 250cc. Photo: Bajaj's official website
    Bajaj Pulsar N250: First higher cc motorcycle launched at Tk3.4 lakh

Related News

  • India to add $5 billion aircraft carrier to fleet to counter China
  • Why is billionaire Jack Ma focusing on food business in China through a new startup ?
  • West's de-risking starts to bite China's prospects
  • Jack Ma gets back into business with ‘Ma’s Kitchen Food’
  • Indian drug manufacturers benefit from Big Pharma interest beyond China

Features

Disadvantaged groups are more exposed to climate effects and less able to recover from damages. A Bangladeshi family travels to a safer location as water enters new areas after the cyclone Aila hit Bangladesh in 2009. Photo: Abir Abdullah

Climate and inequality entwinement imperils us all

1h | Panorama
A lesson on living the moment: 20 years of Kal Ho Naa Ho

A lesson on living the moment: 20 years of Kal Ho Naa Ho

17h | Features
In Barishal’s case, the low-cost of travel via waterways encourages people to migrate to Dhaka and other cities, like Chattogram. Photo: Syed Zakir Hossain

Why nearly a-fifth of people from Barishal moved to Dhaka

18h | Panorama
Photo: Salahuddin Ahmed/TBS

Political unrest hampers admission prep for HSC 2023 intake

19h | Education

More Videos from TBS

Pakistan may lose its opportunity to host the Champions Trophy in 2025

Pakistan may lose its opportunity to host the Champions Trophy in 2025

12h | TBS SPORTS
Climate AI will predict crop yields

Climate AI will predict crop yields

11h | TBS Science
NZ to scrap ‘generational smoking ban’

NZ to scrap ‘generational smoking ban’

14h | TBS World
Musk in Israel to get back advertising!

Musk in Israel to get back advertising!

16h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]